OPINION: The billions allocated for infrastructure require more progressive procurement systems and oversight

Spending on public sector infrastructure over the 2023 medium-term expenditure framework (MTEF) is estimated at R903 billion and the health sector accounts for 5% of this. The well-documented poor maintenance and oversight of projects, also in the health sector, will require close monitoring of trends across the public sector, particularly where procurement and contracting is concerned, writes Zukiswa Kota.

Read More

What next after shortened TB treatment fails in key trial?

The current treatment for drug-susceptible tuberculosis (TB) used in South Africa last for six months, effectively cures TB and is dirt cheap. Two studies in recent years have shown that TB can be cured in four or in some cases even two months, but price and other complications make these treatments tricky to implement. At a conference in Seattle last week, a major trial of an alternative four-month treatment reported disappointing findings. Elri Voigt unpacks the latest findings and asks what the prospects now are for shortening TB treatment.

Read More

OPINION: Budget 2023 – opportunity missed to refocus public health spending?

Budgets, while important, are not the right mechanism to drive the structural change needed to improve the responsiveness of our public health system in meeting the needs of the population. But, argues Russel Rensburg, we can reorient the health system towards meeting the health needs of the population and then let the budget bolster the reforms. Here he provides some suggestions on how to go about it and contrasts that with the budget announced by Minister of Finance Enoch Godongwana this week.

Read More

Vaginal ring to prevent HIV safe to use in late pregnancy and while breastfeeding

A vaginal ring used to prevent HIV infection is safe to use during late pregnancy and while breastfeeding, according to findings presented at a major international HIV conference in Seattle in the United States. The news comes as South Africa prepares for a likely national rollout of the ring and as more research confirms the safety of an HIV prevention pill during pregnancy. It is estimated that offering these products to pregnant and breastfeeding women could avert up to 136 000 new infections in roughly the next decade. Laura Lopez Gonzalez reports.

Read More

In-depth: Some improvement but much more needed to address health needs of key populations

Despite some improvement, the community-led monitoring group Ritshidze’s second report on key populations highlights that sex workers, people who use drugs and LGBTQIA+ community members are often still discriminated against when trying to access public health facilities. This can lead to treatment interruptions and some stopping their clinic visits. Nthusang Lefafa reports.

Read More

OPINION: NHI Bill must still clear many hurdles to ensure adequate medicine access

The Health Department’s recent response to submissions and its own recommendations on amendments to the National Health Insurance Bill sadly does not realise the gravity of the threat to the future of medicine selection and access. As the Bill currently stands, it will leave us at the mercy of advisory committees that bear no duty to be transparent in deciding which medicines people will be able to access under NHI, the authors argue.

Read More

Analysis: Why has the price of this cancer medicine risen and fallen by over a thousand percent since 2016?

Lenalidomide is an important medicine used for the treatment of multiple myeloma – a type of bone marrow cancer that is not curable and typically requires long-term, ongoing treatment. Over the last decade, the price of this drug has fluctuated dramatically in South Africa and patients and their doctors have gone to extreme lengths to access it. Catherine Tomlinson unpacks the remarkable recent history of lenalidomide.

Read More